TB
Theravance Biopharma Inc
TBPH · NASDAQ
$17.08 -1.01% (-$0.18)
1M +0.89%
Market Cap $885.2M
P/E Ratio 16.45x
Div. Yield -
ROE 19.40%
Bulios Fair Price
$22.27
30.4% upside
Trenutna cena
$17.08
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica TBPH trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
66 /100
Fair EV/EBITDA 10.28x
P/S 8.49x
P/B 3.06x
Growth
78 /100
Growing Book val. growth 12.43%
Rev. growth 27.91%
FCF growth N/A
Profitability
76 /100
Strong Net margin 51.58%
Op. margin 4.46%
FCF margin 49.68%
Quality
44 /100
Average ROE 19.40%
ROA 11.45%
Asset turnover 0.22x
Debt
100 /100
Low Current ratio 13.54x
Int. coverage 55.59x
Net debt/EBITDA -2.65x
Stability
11 /100
Unstable Rev. volatility 31.72%
EPS volatility 160.52%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TBPH
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rick E. Winningham
Employees
90
Headquarters
South San Francisco
Prihajajoči dogodki
10 NOV.
Earnings
Upcoming earnings report